Xeris Biopharma Holdings, Inc. company logo
Xeris Biopharma Holdings, Inc. logo

Xeris Biopharma Holdings, Inc. (XERS) Cash From Operations

Annual CFO

-$36.98M$10.04M+21.36%

Summary

Current Value
As of today, XERS annual cash from operations is -$36.98M, up +21.36% on
Historical Performance
XERS annual cash from operations is up +61.29% over the past 3 years, and up +64.56% over the past 5 years
All-Time High Comparison
XERS annual cash from operations is currently -129.88% below its historical high of -$16.09M set on
3-Year Low Comparison
XERS annual cash from operations is +64.06% above its 3-year low of -$102.89M reached on an earlier date
Sector Comparison
XERS annual cash from operations is higher than 30.42% of companies in Healthcare sector

Cash From Operations Chart

Add series to chart
Add series to chart1/6
Series
SUGGESTED SERIES

Performance

XERS Performance
MetricDateValue1Y3Y5Y15Y
Annual Cash From Operations-$36.98M+21.4%+61.3%+64.6%-129.9%
Quarterly Cash From Operations$18.43M+321.9%+203.8%+208.5%+623.8%
TTM Cash From Operations$10.56M+132.3%+109.1%+110.6%+400.0%
Price$7.21+115.2%+586.7%+24.3%
Annual Cash From Investing$4.88M+181.3%-95.0%+304.9%+10000.0%
Annual Cash From Financing$36.17M+2342.3%+32.7%-55.1%+826.4%
Annual Free Cash Flow-$37.85M+23.2%+60.8%+64.1%-134.8%
Annual CAPEX$868.00K-61.6%-20.0%-21.6%+2380.0%
Annual Net Income-$54.84M+11.9%+55.3%+56.3%-315.1%

Cash From Operations Highs

XERS Annual Cash From Operations Highs Comparison
PeriodHighDateCurrent
3Y-$36.98Mat high
5Y-$36.98Mat high
All-$16.09M-129.9%

Cash From Operations Lows

XERS Annual Cash From Operations Lows Comparison
PeriodLowDateCurrent
3Y-$102.89MN/A+64.1%
5Y-$102.89M+64.1%
All-$104.35M+64.6%

Cash From Operations History

YearValueChange
-$36.98M+21.4%
-$47.02M+54.3%
-$102.89M-7.7%
-$95.54M-18.6%
-$80.56M+22.8%
YearValueChange
-$104.35M-85.4%
-$56.28M-128.2%
-$24.66M-53.3%
-$16.09M-

FAQ

  • What is the current annual cash from operations of XERS?

    As of today, XERS annual cash from operations is -$36.98M

  • What is 1-year change in XERS annual cash from operations?

    XERS annual cash from operations is up +21.36% year-over-year

  • What is 3-year change in XERS annual cash from operations?

    XERS annual cash from operations is up +61.29% over the past 3 years

  • How far is XERS annual cash from operations from its all-time high?

    XERS annual cash from operations is currently -129.88% below its historical high of -$16.09M set on December 31, 2016

  • How does XERS annual cash from operations rank versus sector peers?

    XERS annual cash from operations is higher than 30.42% of companies in Healthcare sector

  • When is XERS next annual earnings release?

    The next annual earnings release for XERS is on

Cash From Operations Formula

CFO = + Non Cash Expenses + Changes In

Data Sources & References

  1. XERS Official Website www.xerispharma.com
  2. Most Recent Quarterly Report (10-Q) www.sec.gov/Archives/edgar/data/1867096/000186709625000159/0001867096-25-000159-index.htm
  3. Most Recent Annual Report (10-K) www.sec.gov/Archives/edgar/data/1867096/000186709625000039/0001867096-25-000039-index.htm
  4. XERS Profile on Yahoo Finance finance.yahoo.com/quote/XERS
  5. XERS Profile on NASDAQ.com www.nasdaq.com/market-activity/stocks/xers